Emtricitabine / Tenofovir AF

Also known as Descovy (us)

Save $2,147/mo

114× cheaper

HIV-1 Treatment ( 1.1 ): DESCOVY is a two-drug combination of emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and…

United States

$2,166

per month

India

$19

per month

You save

$2,147

99.12% cheaper in India

238.8K US scripts/yr$512.6M potential annual savings$517.1M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$2,166per month

India price$19per month

You save$2,14799.12% less

Based on 30 units per month. US $72.19 vs India $0.64 per unit.

How many months / courses?

Total over 1 periodSave $2,147$2,166 → $19

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $12,880
Estimated travel cost: − $2,300
Net savings after travel: $10,580

Even after travel, you could come out ahead by about $10,580.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Emtricitabine / Tenofovir AF is filled about 238.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$517.1M

If sourced from India

$4.5M

Potential annual savings

$512.6M

−99%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.